These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 18572420

  • 1. The ischemic etiology of heart failure in diabetics limits reverse left ventricular remodeling after cardiac resynchronization therapy.
    Soliman OI, van Dalen BM, Theuns DA, ten Cate FJ, Nemes A, Jordaens LJ, Geleijnse ML.
    J Diabetes Complications; 2009; 23(5):365-70. PubMed ID: 18572420
    [Abstract] [Full Text] [Related]

  • 2. Baseline predictors of cardiac events after cardiac resynchronization therapy in patients with heart failure secondary to ischemic or nonischemic etiology.
    Soliman OI, Theuns DA, ten Cate FJ, Anwar AM, Nemes A, Vletter WB, Jordaens LJ, Geleijnse ML.
    Am J Cardiol; 2007 Aug 01; 100(3):464-9. PubMed ID: 17659930
    [Abstract] [Full Text] [Related]

  • 3. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
    Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E.
    Circulation; 2006 Jan 17; 113(2):266-72. PubMed ID: 16401777
    [Abstract] [Full Text] [Related]

  • 4. Prediction of cardiac resynchronization therapy response: value of calibrated integrated backscatter imaging.
    Bertini M, Delgado V, den Uijl DW, Nucifora G, Ng AC, van Bommel RJ, Borleffs CJ, Boriani G, Schalij MJ, Bax JJ.
    Circ Cardiovasc Imaging; 2010 Jan 17; 3(1):86-93. PubMed ID: 19920028
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure.
    Porciani MC, Macioce R, Demarchi G, Chiostri M, Musilli N, Cappelli F, Lilli A, Ricciardi G, Padeletti L.
    Eur J Echocardiogr; 2006 Jan 17; 7(1):31-9. PubMed ID: 16378918
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events.
    Park JH, Negishi K, Grimm RA, Popovic Z, Stanton T, Wilkoff BL, Marwick TH.
    Circ Cardiovasc Imaging; 2013 Nov 17; 6(6):864-72. PubMed ID: 24084489
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Value of baseline left lateral wall postsystolic displacement assessed by M-mode to predict reverse remodeling by cardiac resynchronization therapy.
    Sassone B, Capecchi A, Boggian G, Gabrieli L, Saccà S, Vandelli R, Petracci E, Mele D.
    Am J Cardiol; 2007 Aug 01; 100(3):470-5. PubMed ID: 17659931
    [Abstract] [Full Text] [Related]

  • 11. Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapy.
    Buss SJ, Humpert PM, Bekeredjian R, Hardt SE, Zugck C, Schellberg D, Bauer A, Filusch A, Kuecherer H, Katus HA, Korosoglou G.
    JACC Cardiovasc Imaging; 2009 May 01; 2(5):535-43. PubMed ID: 19442937
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy.
    Auger D, van Bommel RJ, Bertini M, Delgado V, Ng AC, Ewe SH, Shanks M, Marsan NA, Mooyaart EA, Witkowski T, Poldermans D, Schalij MJ, Bax JJ.
    Am Heart J; 2010 Oct 01; 160(4):737-43. PubMed ID: 20934569
    [Abstract] [Full Text] [Related]

  • 13. Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE Trial.
    St John Sutton M, Linde C, Gold MR, Abraham WT, Ghio S, Cerkvenik J, Daubert JC, REVERSE Study Group.
    JACC Heart Fail; 2017 Mar 01; 5(3):169-178. PubMed ID: 28254122
    [Abstract] [Full Text] [Related]

  • 14. Reverse of left ventricular volumetric and structural remodeling in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI, Geleijnse ML, Theuns DA, Nemes A, Vletter WB, van Dalen BM, Motawea AK, Jordaens LJ, ten Cate FJ.
    Am J Cardiol; 2008 Mar 01; 101(5):651-7. PubMed ID: 18308015
    [Abstract] [Full Text] [Related]

  • 15. Clinical and echocardiographic correlates of improvement in left ventricular diastolic function after cardiac resynchronization therapy.
    Aksoy H, Okutucu S, Kaya EB, Deveci OS, Evranos B, Aytemir K, Kabakci G, Tokgozoglu L, Ozkutlu H, Oto A.
    Europace; 2010 Sep 01; 12(9):1256-61. PubMed ID: 20478931
    [Abstract] [Full Text] [Related]

  • 16. Left atrial function, a new predictor of response to cardiac resynchronization therapy?
    Feneon D, Behaghel A, Bernard A, Fournet M, Mabo P, Daubert JC, Leclercq C, Donal E.
    Heart Rhythm; 2015 Aug 01; 12(8):1800-6. PubMed ID: 25896013
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy.
    Yu CM, Gorcsan J, Bleeker GB, Zhang Q, Schalij MJ, Suffoletto MS, Fung JW, Schwartzman D, Chan YS, Tanabe M, Bax JJ.
    Am J Cardiol; 2007 Oct 15; 100(8):1263-70. PubMed ID: 17920368
    [Abstract] [Full Text] [Related]

  • 18. Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure.
    Yu CM, Fung JW, Chan CK, Chan YS, Zhang Q, Lin H, Yip GW, Kum LC, Kong SL, Zhang Y, Sanderson JE.
    J Cardiovasc Electrophysiol; 2004 Sep 15; 15(9):1058-65. PubMed ID: 15363081
    [Abstract] [Full Text] [Related]

  • 19. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P, Nijst P, Verbrugge FH, Dupont M, Tang WHW, Mullens W.
    Heart Rhythm; 2018 Jan 15; 15(1):130-136. PubMed ID: 28843420
    [Abstract] [Full Text] [Related]

  • 20. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
    Becker M, Zwicker C, Kaminski M, Napp A, Altiok E, Ocklenburg C, Friedman Z, Adam D, Schauerte P, Marx N, Hoffmann R.
    JACC Cardiovasc Imaging; 2011 Apr 15; 4(4):366-74. PubMed ID: 21492811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.